MedTrace Logo

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

NCT06398522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-05-03

No results posted yet for this study

Summary

This was a double-blind, randomized, placebo-controlled clinical study aiming to assess the effect of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3 on liver steatosis in individuals with NAFLD and metabolic syndrome

Conditions

  • NAFLD
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Food for special medical purposes with calcium butyrate, zinc gluconate and vitamin D3

Food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Claudio Borghi · University of Bologna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06398522 on ClinicalTrials.gov